Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2000
05/17/2000CN1253493A Skin care compositions containing combinations of compounds for mimicking effect on skin of retinoic acid
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253032A Microcapsule containing core material and its producing method
05/17/2000CN1252996A Process for preparing medicinal attapulgite
05/17/2000CN1252990A Vitamin A stable cleaning composition
05/17/2000CN1052420C Chinese medicine for curing burn and traumatic wound and its production method
05/17/2000CN1052410C Medicine for removing scar and its preparing process
05/16/2000US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor
05/16/2000US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents
05/16/2000US6063382 Bacteriostatic and antibacterial agent containing mango kernel component
05/16/2000US6063061 Fragmented polymeric compositions and methods for their use
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/16/2000CA2173403C External therapeutic composition for dermatitis
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/16/2000CA1340994C Treatment of conditions and disease
05/11/2000WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives
05/11/2000WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
05/11/2000WO2000026360A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025772A1 Compositions of and process for producing isotretinoin having low particle size
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025740A1 Topical compositions for enhancing glutathione production
05/11/2000WO2000025724A2 COMPOSITIONS COMPRISING OLEUM $i(MELALEUCA)
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
05/11/2000DE19851334A1 Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung Flexible wound covering based on fibrin, and processes for their preparation
05/11/2000CA2640587A1 Gel compositions
05/11/2000CA2639619A1 Gel compositions
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348728A1 Method for the production of quercetin and isoquercetin derivatives
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347098A1 Compositions of and process for producing isotretinoin having low particle size
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0998949A2 Flexible wound dressing based on fibrin and process for preparation of same
05/10/2000EP0998930A1 Remedial agent for baldness and other diseases
05/10/2000EP0998929A2 Topical pharmaceutical compositions for healing wounds comprising borneol and bismuth subgallate
05/10/2000EP0998915A1 Use of silicon gum to stabilize ascorbic acid, and new compositions containing these compounds
05/10/2000EP0998906A2 Shampoo composition
05/10/2000EP0998900A1 Use of cholesteric liquid crystal polymers as UV-filters in cosmetic and pharmaceutical preparations
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998558A1 Wa545 compositions
05/10/2000EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998264A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract
05/10/2000EP0998263A1 Pyrrolidine derivative hair growth compositions and uses
05/10/2000EP0998262A4 Isoflavonoids for treatment and prevention of aging skin and wrinkles
05/10/2000EP0998262A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles
05/10/2000EP0998251A2 Compositions and methods for inhibiting photoaging of skin
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252791A Arylsecochladiene derivatives
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252693A In-situ generation of zinc pyrithione
05/10/2000CN1252290A Health preparation of fresh Chinese angelica and its preparation
05/10/2000CN1252283A Honey preparation to treat hand dermatitis caused by silk reeling
05/10/2000CN1252271A Chinese medicinal health body-wash and skin care
05/10/2000CN1252270A Wrinkle eliminating nutritive liquid and its preparation
05/10/2000CN1052156C Medicine for curing acne
05/10/2000CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds
05/09/2000US6060604 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
05/09/2000US6060512 Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060468 N-substituted azaheterocyclic compounds
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/09/2000US6060070 Isoflavonoids for treatment and prevention of aging skin and wrinkles
05/09/2000US6060061 Method for preventing or treating disorders involving an inflammatory process
05/09/2000US6060042 Use of cholesteric, liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024895A2 Method and model for hair pigmentation
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 1065